CP
MDXG icon

Castleview Partners’s MiMedx Group MDXG Stock Holding History

Castleview Partners’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-270
Closed -$1.87K – 762
2024
Q2 		$1.87K Hold
270
– – ﹤0.01% 748
2024
Q1 		$2.08K Hold
270
– – ﹤0.01% 736
2023
Q4 		$2.37K Hold
270
– – ﹤0.01% 690
2023
Q3 		$1.97K Sell
270
-13,900
-98% -$104K ﹤0.01% 557
2023
Q2 		$93.7K Hold
14,170
– – 0.08% 192
2023
Q1 		$48.3K Sell
14,170
-2,000
-12% -$7.75K 0.04% 270
2022
Q4 		$45K Hold
16,170
– – 0.04% 240
2022
Q3 		$46K Buy
16,170
+13,103
+427% +$46.6K 0.04% 264
2022
Q2 		$78.5K Sell
3,067
-40,285
-93% -$158K 0.06% 238
2022
Q1 		$204K Sell
43,352
-212,242
-83% -$1.04M 0.13% 160
2021
Q4 		$42.3K Buy
+255,594
New +$1.78M 0.34% 30
2021
Q2 		$677K Buy
+54,083
New +$586K 0.3% 71
2018
Q1 		$389K Buy
+55,743
New +$649K 0.32% 74

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Castleview Partners's MDXG Position: Q3 2024 in Review

Castleview Partners sold out of MiMedx Group (MDXG) in Q3 2024, closing a stake of 270 shares — an estimated $1.87K sold.

Castleview Partners first reported a position in MDXG in Q1 2018 and held it in 13 quarters. The position peaked at $677K in Q2 2021. 194 funds tracked by Wall St. Rank hold MDXG as of Q3 2024.

  • Castleview Partners reported no remaining MiMedx Group position as of Q3 2024 after selling out during the quarter.
  • Castleview Partners sold 270 MiMedx Group shares in Q3 2024, an estimated $1.87K.
  • Castleview Partners first reported a position in MiMedx Group in Q1 2018 and held it in 13 quarters.
  • Castleview Partners's MiMedx Group position peaked at $677K in Q2 2021.
  • 194 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2024.

Based on Castleview Partners's 13F filing for Q3 2024, filed 9 Oct 2024.